Viewing Study NCT04489433


Ignite Creation Date: 2025-12-25 @ 2:48 AM
Ignite Modification Date: 2025-12-26 @ 1:29 AM
Study NCT ID: NCT04489433
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2025-12-18
First Post: 2020-07-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Compassionate Use Program to Access Trametinib and Dabrafenib for Patients With BRAF Mutation-positive Metastatic Melanoma
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module